Medicine
Desvenlafaxine 25 mg extended-release tablet
Desvenlafaxine 25 mg extended-release tablet is a generic prescription medicine for oral use, made by 10 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59°…
Key facts
- Active ingredient (INN)
- Desvenlafaxine
- Brand
- Sold under the generic name
- Strength
- 25 mg
- Dosage form
- Extended-release tablet
- Route
- Oral
- Packs
- 100 tablets, 30 tablets, 80 tablets and 44 more
- Manufacturers
- Alembic PharmaceuticalsIndiaLupinIndiaBryant Ranch PrepackBreckenridge PharmaceuticalAdvagen PharmaActavis PharmaHikma PharmaceuticalsSlate Run Pharmaceuticals10 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N06AX23 Desvenlafaxine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 March 2017
- Identifiers
- RxCUI 1607617, 1874553, 1874559DailyMed set ID b14695b4-c35e-4902-8144-d31d698b1c58, 5bd203d2-477e-4d12-a875-cb8009f42410, 7ee04e8c-ce6c-450d-9122-2bffd170bfd7 +14NDC 50090-7190, 46708-542, 50090-7468 +14Application ANDA204028, ANDA204003, ANDA204172 +4
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 10 labelers. The register lists 47 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet, extended release in 1 carton | 46708-542-10 | Alembic PharmaceuticalsIndia | 14 September 2018 |
| 30 tablet, extended release in 1 bottle | 46708-542-30 | Alembic PharmaceuticalsIndia | 14 September 2018 |
| 100 tablet, extended release in 1 bottle | 46708-542-31 | Alembic PharmaceuticalsIndia | 14 September 2018 |
| 80 tablet, extended release in 1 carton | 46708-542-80 | Alembic PharmaceuticalsIndia | 14 September 2018 |
| 90 tablet, extended release in 1 bottle | 46708-542-90 | Alembic PharmaceuticalsIndia | 14 September 2018 |
| 1000 tablet, extended release in 1 bottle | 46708-542-91 | Alembic PharmaceuticalsIndia | 14 September 2018 |
| 30 tablet, film coated, extended release in 1 bottle | 68180-604-06 | LupinIndia | 25 August 2022 |
| 30 tablet, extended release in 1 bottle | 0591-4060-30 | Actavis Pharma | 1 March 2017 |
| 1000 tablet, extended release in 1 package | 72888-175-00 | Advagen Pharma | 14 March 2023 |
| 500 tablet, extended release in 1 package | 72888-175-05 | Advagen Pharma | 14 March 2023 |
| 30 tablet, extended release in 1 package | 72888-175-30 | Advagen Pharma | 14 March 2023 |
| 90 tablet, extended release in 1 package | 72888-175-90 | Advagen Pharma | 14 March 2023 |
| 100 tablet, extended release in 1 bottle | 51991-006-01 | Breckenridge Pharmaceutical | 28 November 2018 |
| 1000 tablet, extended release in 1 bottle | 51991-006-10 | Breckenridge Pharmaceutical | 28 November 2018 |
| 100 tablet, extended release in 1 carton | 51991-006-11 | Breckenridge Pharmaceutical | 28 November 2018 |
| 30 tablet, extended release in 1 bottle | 51991-006-33 | Breckenridge Pharmaceutical | 28 November 2018 |
| 80 tablet, extended release in 1 carton | 51991-006-80 | Breckenridge Pharmaceutical | 28 November 2018 |
| 90 tablet, extended release in 1 bottle | 51991-006-90 | Breckenridge Pharmaceutical | 28 November 2018 |
| 30 tablet, film coated, extended release in 1 bottle | 0054-0603-13 | Hikma Pharmaceuticals | 29 August 2017 |
| 30 tablet, extended release in 1 bottle, plastic | 70436-036-04 | Slate Run Pharmaceuticals | 5 January 2021 |
| 30 tablet, film coated, extended release in 1 bottle | 63629-7524-1 | Bryant Ranch Prepack | 24 January 2025 |
| 60 tablet, film coated, extended release in 1 bottle | 63629-7524-2 | Bryant Ranch Prepack | 24 January 2025 |
| 90 tablet, film coated, extended release in 1 bottle | 63629-7524-3 | Bryant Ranch Prepack | 24 January 2025 |
| 120 tablet, film coated, extended release in 1 bottle | 63629-7524-4 | Bryant Ranch Prepack | 24 January 2025 |
| 30 tablet, extended release in 1 bottle, plastic | 71335-1975-1 | Bryant Ranch Prepack | 14 October 2021 |
| 60 tablet, extended release in 1 bottle, plastic | 71335-1975-2 | Bryant Ranch Prepack | 18 July 2024 |
| 90 tablet, extended release in 1 bottle, plastic | 71335-1975-3 | Bryant Ranch Prepack | 18 July 2024 |
| 120 tablet, extended release in 1 bottle, plastic | 71335-1975-4 | Bryant Ranch Prepack | 14 October 2021 |
| 30 tablet, extended release in 1 bottle | 71335-2130-1 | Bryant Ranch Prepack | 13 March 2023 |
| 60 tablet, extended release in 1 bottle | 71335-2130-2 | Bryant Ranch Prepack | 13 March 2023 |
| 90 tablet, extended release in 1 bottle | 71335-2130-3 | Bryant Ranch Prepack | 1 November 2024 |
| 120 tablet, extended release in 1 bottle | 71335-2130-4 | Bryant Ranch Prepack | 1 November 2024 |
| 30 tablet, extended release in 1 bottle | 71335-2490-1 | Bryant Ranch Prepack | 18 September 2024 |
| 60 tablet, extended release in 1 bottle | 71335-2490-2 | Bryant Ranch Prepack | 18 September 2024 |
| 90 tablet, extended release in 1 bottle | 71335-2490-3 | Bryant Ranch Prepack | 18 September 2024 |
| 120 tablet, extended release in 1 bottle | 71335-2490-4 | Bryant Ranch Prepack | 18 September 2024 |
| 30 tablet, film coated, extended release in 1 bottle | 71335-2494-1 | Bryant Ranch Prepack | 16 September 2024 |
| 60 tablet, film coated, extended release in 1 bottle | 71335-2494-2 | Bryant Ranch Prepack | 16 September 2024 |
| 90 tablet, film coated, extended release in 1 bottle | 71335-2494-3 | Bryant Ranch Prepack | 16 September 2024 |
| 120 tablet, film coated, extended release in 1 bottle | 71335-2494-4 | Bryant Ranch Prepack | 16 September 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Desvenlafaxine 25 mg extended-release tablet.
Other strengths and forms of Desvenlafaxine
Clinical summary
Desvenlafaxine is a serotonin and norepinephrine reuptake inhibitor indicated for the treatment of adults with major depressive disorder (MDD). It is available as extended-release tablets for oral use. MedsAcross supplies Desvenlafaxine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about DesvenlafaxineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Pristiq Extended-Release prescribing information (Wyeth Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Desvenlafaxine 25 mg extended-release tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.